Nuplazid
| Chemical Name | pimavanserin |
| Dosage Form | Tablet (oral; 10 mg); Capsule (oral; 34 mg) |
| Drug Class | Antipsychotics |
| System | Nervous |
| Company | Acadia Pharmaceuticals Inc. |
| Approval Year | 2016 |
Indication
- To treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson’s disease.